[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Page 6550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02411]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
the National AIDS Control Program, Programme National de Lutte contre 
le VIH/SIDA (PNLS), Democratic Republic of Congo

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $500,000 for Year 1 of funding to the Programme 
National de Lutte contre le VIH/SIDA (PNLS). The award will strengthen 
Strategic Information (SI) activities, laboratory quality assurance 
services, and surveillance of new infections in Democratic Republic of 
Congo (DRC). This support will enhance the antiretroviral therapy (ART) 
cohort monitoring and delivery of HIV/AIDS services for the epidemic 
control in DRC. Funding amounts for years 2-5 will be set at 
continuation.

DATES: The period for this award will be September 30, 2022 through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Kaee Ross, Center for Global Health, 
Centers for Disease Control and Prevention, U.S. Embassy DRC, 498 Ave 
Col Lukusa, Kinshasa, Gombe, DRC, Telephone: 800-232-6348, email: 
[email protected].

SUPPLEMENTARY INFORMATION: The single-source award will improve data 
collection and analysis to produce a factual basis for evaluation and 
improvement of the HIV prevention, care, and treatment program in the 
DRC. The project will build capacity in DRC to have available, reliable 
data transmitted promptly for decision-making. Furthermore, the project 
will sustain quality assurance for rapid tests to ensure accuracy of 
results, and the monitoring of rapid tests used in the field.
    The PNLS is a specialized program run by the Ministry of Health 
(MOH) in the DRC. Created on August 5, 2015 by Ministerial Decision No. 
449/MSLS/CAB, the PNLS has been authorized and tasked to lead and 
coordinate the fight against the HIV/AIDS epidemic to achieve epidemic 
control. The PNLS is the governmental authority with the normative and 
regulatory role in the implementation of STI and HIV/AIDS control 
activities in the Health Zones (HZ). The PNLS has the authority to 
organize, review, and validate all data relative to HIV-AIDS in 
country. In addition, PNLS has the mission to control the quality of 
rapid test results provided by health care workers at facilities and to 
monitor how rapid tests are working in the field. Accordingly, PNLS has 
the sole authority and is uniquely qualified to perform the anticipated 
activities for this award.

Summary of the Award

    Recipient: the Programme National de Lutte contre le VIH/SIDA 
(PNLS).
    Purpose of the Award: The purpose of this award is to strengthen SI 
activities, laboratory quality assurance services, and surveillance of 
new infections in DRC. Support from this award will enhance ART cohort 
monitoring and delivery of HIV/AIDS services for control of the 
epidemic in DRC.
    Amount of Award: The approximate year 1 funding amount will be 
$500,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the 
availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003).
    Period of Performance: September 30, 2022 through September 29, 
2027.

    Dated: February 1,2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-02411 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P